Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Brandon May
Brandon May is a freelance medical writer.
Articles by Brandon May
iStopMM: Screening for MGUS Enables Earlier Detection and Intervention
Brandon May
Myeloma
|
November 14, 2022
Researchers explored whether population-based screening for MGUS could increase the frequency of patients with multiple ...
Read More
Circulating Tumor DNA Could Be a New Noninvasive Tool for CNS Lymphoma Prediction
Brandon May
Aggressive B-Cell Lymphoma
|
November 14, 2022
Circulating tumor DNA accurately reflects tumor burden and may serve as a useful clinical biomarker for risk and outcome in ...
Read More
Study REVEALs Thrombotic Complications as Leading Cause of Death in Older Patients with Polycythemia Vera
Brandon May
Myeloproliferative Neoplasms
|
May 30, 2023
REVEAL is the largest prospective and contemporary cohort of patients with PV in the United States.
Read More
Response-Based Dose-Reduction Strategy for Ponatinib Optimizes Risk-Benefit Ratio in CP-CML
Brandon May
Chronic Myeloid Leukemia
|
September 30, 2024
The OPTIC study evaluated a response-based dose-reduction strategy to optimize the benefit-risk of a TKI in CP-CML.
Read More
Pirtobrutinib Shows Promising Efficacy in Previously Treated CLL/SLL
Brandon May
Chronic Lymphocytic Leukemia
|
February 2, 2023
In patients with previously treated CLL and SLL, pirtobrutinib was safe and associated with high rates of response.
Read More
High Complete Response Rates with Magrolimab Triplet in High-Risk Acute Myeloid Leukemia
Brandon May
Acute Myeloid Leukemia
|
February 2, 2023
Three-quarters of evaluable patients experienced complete cytogenetic complete response.
Read More
HLH Is a Possible New CAR T-Cell–Associated Toxicity in Young Patients
Brandon May
Transplantation & Cellular Therapy
|
January 21, 2022
A study has characterized HLH–like manifestations as a CRS variant in certain young patients with leukemia/lymphoma.
Read More
Late Mortality After Transplant Has Improved—for Certain Patients
Brandon May
Transplantation & Cellular Therapy
|
November 14, 2022
Life expectancy has improved since 1974 but remains 20.8% lower compared with the general population.
Read More
Long-Term Data Show Cilta-Cel Yields Early, Durable Responses in Relapsed Refractory Multiple Myeloma
Brandon May
Myeloma
|
November 14, 2022
Take-aways: ...
Read More